FR1782M - Le nicotinate de cétyle comme antalgique et révulsif et les compositions pharmaceutiques pour son administration, notamment par voie percutanée. - Google Patents

Le nicotinate de cétyle comme antalgique et révulsif et les compositions pharmaceutiques pour son administration, notamment par voie percutanée.

Info

Publication number
FR1782M
FR1782M FR888409A FR888409A FR1782M FR 1782 M FR1782 M FR 1782M FR 888409 A FR888409 A FR 888409A FR 888409 A FR888409 A FR 888409A FR 1782 M FR1782 M FR 1782M
Authority
FR
France
Prior art keywords
repellant
nicotinate
analgesic
cetyl
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR888409A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RECH S PHARMACOTECHNIQUES SOC
Original Assignee
RECH S PHARMACOTECHNIQUES SOC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RECH S PHARMACOTECHNIQUES SOC filed Critical RECH S PHARMACOTECHNIQUES SOC
Application granted granted Critical
Publication of FR1782M publication Critical patent/FR1782M/fr
Priority claimed from FR88409A external-priority patent/FR1515084A/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
FR888409A 1966-12-21 1962-02-17 Le nicotinate de cétyle comme antalgique et révulsif et les compositions pharmaceutiques pour son administration, notamment par voie percutanée. Expired FR1782M (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR88409A FR1515084A (fr) 1965-12-22 1966-12-21 Nouvelles compositions de résines thermodurcissables du type au formol très résistantes aux chocs

Publications (1)

Publication Number Publication Date
FR1782M true FR1782M (fr) 1963-04-22

Family

ID=87575758

Family Applications (1)

Application Number Title Priority Date Filing Date
FR888409A Expired FR1782M (fr) 1966-12-21 1962-02-17 Le nicotinate de cétyle comme antalgique et révulsif et les compositions pharmaceutiques pour son administration, notamment par voie percutanée.

Country Status (1)

Country Link
FR (1) FR1782M (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0057797A3 (en) * 1981-02-03 1982-09-08 Imperial Chemical Industries Plc Process for the extraction of metal values and novel metal extractants
US6015821A (en) * 1995-05-01 2000-01-18 Horrobin; David Frederick Nicotinic acid esters and pharmaceutical compositions containing them
USRE40480E1 (en) * 1995-05-01 2008-09-02 Scarista Limited 1,3-Propane diol esters and ethers and methods for their use in drug delivery
USRE40546E1 (en) * 1996-05-01 2008-10-21 Scarista, Ltd. 1,3-Propane diol esters and ethers and methods for their use in drug delivery

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0057797A3 (en) * 1981-02-03 1982-09-08 Imperial Chemical Industries Plc Process for the extraction of metal values and novel metal extractants
US4525330A (en) * 1981-02-03 1985-06-25 Imperial Chemical Industries Limited Process for the extraction of metal values and novel metal extractants
US6015821A (en) * 1995-05-01 2000-01-18 Horrobin; David Frederick Nicotinic acid esters and pharmaceutical compositions containing them
USRE40480E1 (en) * 1995-05-01 2008-09-02 Scarista Limited 1,3-Propane diol esters and ethers and methods for their use in drug delivery
USRE43632E1 (en) * 1995-05-01 2012-09-04 Scarista, Ltd. 1,3-propane diol esters and ethers and methods for their use in drug delivery
USRE40546E1 (en) * 1996-05-01 2008-10-21 Scarista, Ltd. 1,3-Propane diol esters and ethers and methods for their use in drug delivery

Similar Documents

Publication Publication Date Title
ES368496A1 (es) Procedimiento para la preparacion de soluciones acuosas de doxiciclina, para uso parenteral, oral y local.
NL187259C (nl) Werkwijze voor het bereiden van preparaten, die een werkzaam bestanddeel met een geregelde snelheid afgeven.
NL163213B (nl) Werkwijze voor de bereiding van preparaten met anti- bacteriele werking, die als werkzame verbinding een gesubstitueerd benzyldiaminopyrimidine bevatten, en werkwijze voor de bereiding van de werkzame verbinding.
FR2126M (fr) Nouveaux médicaments constitués par des 4-oxo-1,8-naphtyridines substitués en position 3.
FR1466378A (fr) Système de palier, notamment pour outils pour le forage du sol
NL144604B (nl) Werkwijze voor het bereiden van analgetisch werkzame benzazocineverbindingen, werkwijze voor het bereiden van analgetisch werkzame preparaten en gevormd geneesmiddel.
NL188981B (nl) Farmaceutisch preparaat met kankerbestrijdende werking, alsmede antrachinonderivaten die geschikt zijn als werkzaam bestanddeel daarvan.
FR1782M (fr) Le nicotinate de cétyle comme antalgique et révulsif et les compositions pharmaceutiques pour son administration, notamment par voie percutanée.
FR2852M (fr) Préparations pharmaceutiques agissant sur le systeme nerveux central.
NL142950B (nl) Werkwijze voor de bereiding van een 1-aryloxy-2-hydroxy-3-isopropylaminopropaanderivaat en zouten daarvan, alsmede voor de bereiding van (beta)-adrenolytisch werkzame farmaceutische preparaten die deze verbinding als actief bestanddeel bevatten.
FR1726M (fr) Nouvel anti-algique et antirhumatismal : le nicotinate de salicyloylglycol et les compositions pharmaceutiques pour son administration, notamment par voie percutanée.
NL152169B (nl) Werkwijze ter bereiding van farmaceutische preparaten voor de behandeling van seborrhoea langs orale weg, alsmede aldus verkregen gevormde farmaceutische preparaten.
FR2015M (fr) Perfectionnements aux préparations pharmaceutiques.
NL175382C (nl) Werkwijze ter bereiding van antiflogistisch, analgetisch of antipyretisch werkzame farmaceutische preparaten, alsmede werkwijze ter bereiding van voor gebruik bij die werkwijze geschikte o-anilinofenylaceetamidederivaten.
FR3442M (fr) L'hexachlorophénate de tuaminoheptane comme antiseptique et vasoconstricteur local et les compositions pharmaceutiques pour son administration.
FR3880M (fr) Nouveaux médicaments, en particulier pour le traitement de la tuberculose.
NL142592B (nl) Werkwijze voor het bereiden van amidinen of daarvan afgeleide zuur-additiezouten, die werkzaam zijn als antagonisten van 5-hydroxytryptamine, en van farmaceutische preparaten, die ten minste een van deze verbindingen als werkzame verbinding bevatten.
FR2046M (fr) Le tétranicotinate de pentaérythrite comme lipotrope et les compositions pharmaceutiques pour son administration.
FR1940M (fr) Le nicotinate de pyridoxine comme lipotrope, vasodilatateur et eutrophique cutané et les compositions pharmaceutiques pour son administration.
NL139239B (nl) Werkwijze voor de bereiding van anti-inflammatoire en analgetische preparaten, die als werkzame verbinding 1,2-difenyl-4-gesubstitueerde pyrazolidinedionen-3,5 bevatten, aldus verkregen gevormde preparaten, en werkwijze voor de bereiding van de daarin toegepaste actieve verbindingen.
FR2501M (fr) Le succinate de di-p.acétaminophénol comme antirhumatismal analgésique antipyrétique et les compositions pharmaceutiques pour son administration.
FR3422M (fr) Les propionates, neutre et basique, de quinine comme antifongiques et bactéricides et les compositions pharmaceutiques pour leur administration.
FR1959M (fr) Le pantothénate de pyridoxine comme lipotrope et eutrophique cutané et les compositions pharmaceutiques pour son administration.
FI46254C (fi) Menetelmä pregna-4,6-dieeni-3,20-dioni-6-metyyli-(17alfa,16alfa-d)-2'- metyylioksatsoliinin valmistamiseksi.
FR2128M (fr) L'aspartate d'heptaminol comme antiasthénique et défatigant et les compositions pharmaceutiques pour son administration.